Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523700 · ClinicalTrials.gov registry record · NA
Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05523700 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 10 participants.
The verdict
NCT05523700, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will evaluate the use of a mobile application in improving the patient-reported health outcome measures (PROMIS) for patients diagnosed with advanced stage ovarian, fallopian tube, and primary peritoneal cancer. The application will incorporate clinical data from the patient's medical chart as well as capture patient-reported outcome measures on an ongoing basis to better inform physicians and the care team so that necessary interventions may be implemented.
Interventions
- OTHER Mobile Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-10-17 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05523700
The ClinicalTrials.gov registry entry for NCT05523700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile Application is the first listed.
NCT05523700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05523700 about?
NCT05523700 is a clinical study titled "Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)". This study will evaluate the use of a mobile application in improving the patient-reported health outcome measures (PROMIS) for patients diagnosed with advanced stage ovarian, fallopian tube, and primary peritoneal cancer. The application will incorporate clinical data from the patient's medical cha...
What is the current status of trial NCT05523700?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-10-17. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT05523700?
The interventions under investigation include: Mobile Application (OTHER).
Who is sponsoring clinical trial NCT05523700?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.